BALVERSA

erdafitinib · Janssen Products LP

Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for BALVERSA, covering 2017-06-23 to 2026-04-28. Get the full timeline:

Most recent: EMA Authorised: Balversa (Erdafitinib) — Janssen-Cilag International N.V.